Suspension of trading
Acorda Therapeutics Share Price OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 13/24/13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 07/24/07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% |
| 1 week | 0 |  | 0.02 |
| 1 month | 0 | | 0.15 |
| 3 years | 0 | | 99.8 |
| 5 years | 0 | | 535.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Ali
COO | Chief Operating Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -10.00% | -99.92% | -99.98% | 16.77T | |
| +0.68% | +5.92% | +80.45% | +137.78% | 5.91TCr | |
| +2.32% | +5.03% | +75.51% | +94.88% | 5.52TCr | |
| +3.86% | +6.93% | -11.32% | -9.53% | 2.47TCr | |
| +4.30% | +7.95% | +14.11% | +437.83% | 2.42TCr | |
| +4.74% | +13.68% | +45.58% | -1.42% | 1.97TCr | |
| -0.29% | +9.78% | +44.62% | -27.94% | 1.76TCr | |
| 0.00% | +20.78% | +178.93% | +360.74% | 1.62TCr | |
| +3.50% | +1.97% | +21.02% | +191.95% | 1.4TCr | |
| +6.72% | +19.38% | +42.82% | - | 1.48TCr | |
| Average | +2.87% | +8.57% | +39.18% | +120.48% | 2.73TCr | |
| Weighted average by Cap. | +2.46% | +6.47% | +59.06% | +137.71% |
Employees
-
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
Select your edition
All financial news and data tailored to specific country editions
